Next Article in Journal
Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases
Next Article in Special Issue
The Chemistry of Curcumin: From Extraction to Therapeutic Agent
Previous Article in Journal
The Role of Acyl-Glucose in Anthocyanin Modifications
Previous Article in Special Issue
Curcumin Reverse Methicillin Resistance in Staphylococcus aureus
Article Menu

Export Article

Open AccessArticle
Molecules 2014, 19(11), 18767-18780; doi:10.3390/molecules191118767

Curcumin Protects against CCl4-Induced Liver Fibrosis in Rats by Inhibiting HIF-1α Through an ERK-Dependent Pathway

1
China Military Institute of Chinese Medicine, 302 Military Hospital of China, Beijing 100039, China
2
Pharmacy College, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
3
State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China
4
Research and Technology Service Center, 302 Military Hospital of China, Beijing 100039, China
5
Department of Integrative Medical Center, 302 Military Hospital of China, Beijing 100039, China
*
Author to whom correspondence should be addressed.
Received: 4 September 2014 / Revised: 21 October 2014 / Accepted: 27 October 2014 / Published: 17 November 2014
(This article belongs to the Special Issue Curcumin, Inflammation, and Chronic Diseases: How are They Linked?)
View Full-Text   |   Download PDF [4460 KB, uploaded 17 November 2014]   |  

Abstract

The ERK/HIF-1α signaling pathway is believed to play an important role in the genesis of progressive fibrosis. An increasing expression of HIF-1α and ERK accompanies CCl4-induced liver fibrosis in rats. Curcumin is verified to have antifibrotic effects in several kinds of liver fibrosis models. There is no specific evidence illustrating a connection between curcumin and the HIF-1α/ERK pathway in rat liver fibrosis induced by CCl4. In this study, liver fibrosis was induced by CCl4 in treated rats. The data demonstrated that curcumin was able to attenuate liver fibrosis and inhibit the proliferation of HSC. Moreover, curcumin could remarkably elevate the hepatic function by decreasing serum levels of ALT, AST and ALP, and increasing levels of ALB, TP and α-SMA, Col III mRNA expression. Meanwhile, ECM status could also be reflected by curcumin treatment. The alleviation with curcumin treatment was associated with inhibition of HIF-1α and phosphor-ERK. This study indicates that curcumin alleviates fibrosis by reducing the expression of HIF-1α partly through the ERK pathway. View Full-Text
Keywords: curcumin; carbon tetrachloride; liver fibrosis; hypoxia inducible factor curcumin; carbon tetrachloride; liver fibrosis; hypoxia inducible factor
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Zhao, Y.; Ma, X.; Wang, J.; He, X.; Hu, Y.; Zhang, P.; Wang, R.; Li, R.; Gong, M.; Luo, S.; Xiao, X. Curcumin Protects against CCl4-Induced Liver Fibrosis in Rats by Inhibiting HIF-1α Through an ERK-Dependent Pathway. Molecules 2014, 19, 18767-18780.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top